Sleep Quality and Pain Medication Use Following Arthroscopic Rotator Cuff Repair
Status unconfirmed · Not applicable
Conditions studied: Sleep Disturbance
In brief
The purpose of this study is to investigate if oral melatonin reduces postoperative sleep 18 disturbances and narcotics use. We will enroll patients undergoing primary arthroscopic rotator 19 cuff repair (ARCR) at the Rothman Institute.
Key facts
- Study ID
- NCT04278677
- Run by
- Rothman Institute Orthopaedics
- People needed
- 80
- Starts
- 2020-03-01
- Expected to finish
- 2021-03-01
- Last updated by the study team
- 2020-02-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who undergo primary ARCR
- Patient willing and able to complete postoperative surveys
You may not qualify if…
- Daily melatonin use for > 1 week during the last 3 months
- Irreparable tears
- Revision rotator cuff repairs
- Severe glenohumeral arthritis
- Concurrent adhesive capsulitis
- Age less than 18
- Pregnancy
- History of substance abuse (drug or alcohol)
- Workman's comp patient or patient has current litigation pending
- Allergy to melatonin
- History of delirium/psychiatric/depression/ on antidepressants
- History of insomnia/ on sleep aid medication
- Use of prescription sedatives
- use of Zelboraf (vemurafenib)
- Use of all blood thinning medications besides aspirin (warfarin, plavix, lovenox, etc.)
- Sleep apnea
Where it is running
- Rothman Orthopaedics at Egg Harbor Township — Egg Harbor, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.